MiR-615 inhibited cell proliferation and cell cycle of human breast cancer cells by suppressing of AKT2 expression

International Journal of Clinical and Experimental Medicine

Volumn 8, Issue 3, 2015, Pages 3801-3808

  Bai, Yang ^a   Li, Jingyan ^b   Li, Jie ^a   Liu, Yonghong ^a   Zhang, Bo ^a  

^a CANGZHOU CENTRAL HOSPITAL   (China)

^b Department of Radiology Hebei province Cangzhou Hospital of integrated traditional and Western Medicine (Cangzhou NO 2 Hospital)   (China)

Author keywords

AKT2; Breast cancer; Cell cycle; Cell proliferation; MiR 615

Indexed keywords

MICRORNA; MICRORNA 615; PROTEIN KINASE B BETA; PROTEIN P21; PROTEIN P27; RETINOBLASTOMA PROTEIN; UNCLASSIFIED DRUG;

3' UNTRANSLATED REGION; ADULT; ANCHORAGE INDEPENDENT GROWTH; ARTICLE; BIOINFORMATICS; BREAST CANCER; CELL CYCLE ARREST; CELL CYCLE G1 PHASE; CELL CYCLE S PHASE; CELL PROLIFERATION; CELL VIABILITY; COLONY FORMATION; DOWN REGULATION; FEMALE; FLOW CYTOMETRY; HUMAN; HUMAN CELL; MTT ASSAY; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; REAL TIME POLYMERASE CHAIN REACTION; UPREGULATION; WESTERN BLOTTING;

EID: 84929378038     PISSN: None     EISSN: 19405901     Source Type: Journal    
DOI: None     Document Type: Article

References (21)

1. Jemal A, Bray F, Center MM, Ferlay J, Ward E and Forman D. Global cancer statistics. CA Cancer J Clin 2011; 61: 69-90.
2. DeSantis C, Siegel R, Bandi P and Jemal A. Breast cancer statistics, 2011. CA Cancer J Clin 2011; 61: 409-418.
3. Dalmay T. Mechanism of miRNA-mediated repression of mRNA translation. Essays Biochem 2013; 54: 29-38.
4. van Kouwenhove M, Kedde M and Agami R. MicroRNA regulation by RNA-binding proteins and its implications for cancer. Nat Rev Cancer 2011; 11: 644-656.
5. Calin GA and Croce CM. MicroRNA signatures in human cancers. Nat Rev Cancer 2006; 6: 857-866.
6. Zhang ZG, Chen WX, Wu YH, Liang HF and Zhang BX. MiR-132 prohibits proliferation, invasion, migration, and metastasis in breast cancer by targeting HN1. Biochem Biophys Res Commun 2014; 454: 109-114.
7. Shen F, Cai WS, Feng Z, Li JL, Chen JW, Cao J and Xu B. MiR-492 contributes to cell proliferation and cell cycle of human breast cancer cells by suppressing SOX7 expression. Tumour Biol 2014; 36: 1913-21.
8. Wang XY, Wu MH, Liu F, Li Y, Li N, Li GY and Shen SR. Differential miRNA expression and their target genes between NGX6-positive and negative colon cancer cells. Mol Cell Biochem 2010; 345: 283-290.
9. Wang L, Yao J, Zhang X, Guo B, Le X, Cubberly M, Li Z, Nan K, Song T and Huang C. miRNA-302b suppresses human hepatocellular carcinoma by targeting AKT2. Mol Cancer Res 2014; 12: 190-202.
10. Ding Z, Xu F, Li G, Tang J, Tang Z, Jiang P and Wu H. Knockdown of Akt2 Expression by ShRNA Inhibits Proliferation, Enhances Apo-ptosis, and Increases Chemosensitivity to Paclitaxel in Human Colorectal Cancer Cells. Cell Biochem Biophys 2014; 71: 383-8.
11. Chou Y, Lin HC, Chen KC, Chang CC, Lee WS and Juan SH. Molecular mechanisms underlying the anti-proliferative and anti-migratory effects of folate on homocysteine-challenged rat aortic smooth muscle cells. Br J Pharmacol 2013; 169: 1447-1460.
12. Rajabi HN, Takahashi C and Ewen ME. Re-tinoblastoma Protein and MyoD Function To-gether to Effect the Repression of Fra-1 and in Turn Cyclin D1 during Terminal Cell Cycle Arrest Associated with Myogenesis. J Biol Chem 2014; 289: 23417-23427.
13. Meng Y, Zou Q, Liu T, Cai X, Huang Y and Pan J. microRNA335 inhibits proliferation, cellcycle progression, colony formation, and invasion via targeting PAX6 in breast cancer cells. Mol Med Rep 2015; 11: 379-385.
14. Fu P, Du F, Yao M, Lv K and Liu Y. MicroRNA-185 inhibits proliferation by targeting c-Met in human breast cancer cells. Exp Ther Med 2014; 8: 1879-1883.
15. Zhao HJ, Ren LL, Wang ZH, Sun TT, Yu YN, Wang YC, Yan TT, Zou W, He J, Zhang Y, Hong J and Fang JY. MiR-194 deregulation contributes to colorectal carcinogenesis via targeting AKT2 pathway. Theranostics 2014; 4: 1193-1208.
16. Zhang Y, Guo X, Xiong L, Yu L, Li Z, Guo Q, Li Z, Li B and Lin N. Comprehensive analysis of microRNA-regulated protein interaction network reveals the tumor suppressive role of microRNA-149 in human hepatocellular carcinoma via targeting AKT-mTOR pathway. Mol Cancer 2014; 13: 253.
17. Iliopoulos D, Polytarchou C, Hatziapostolou M, Kottakis F, Maroulakou IG, Struhl K and Tsichlis PN. MicroRNAs differentially regulated by Akt isoforms control EMT and stem cell renewal in cancer cells. Sci Signal 2009; 2: ra62.
18. Fohlin H, Perez-Tenorio G, Fornander T, Skoog L, Nordenskjold B, Carstensen J and Stal O. Akt2 expression is associated with good long-term prognosis in oestrogen receptor positive breast cancer. Eur J Cancer 2013; 49: 1196-1204.
19. Clark AR and Toker A. Signalling specificity in the Akt pathway in breast cancer. Biochem Soc Trans 2014; 42: 1349-1355.
20. Chin YR, Yuan X, Balk SP and Toker A. PTEN-deficient tumors depend on AKT2 for maintenance and survival. Cancer Discov 2014; 4: 942-955.
21. Hsu YH, Chang CC, Yang NJ, Lee YH and Juan SH. RhoA-mediated inhibition of vascular endothelial cell mobility: positive feedback th-rough reduced cytosolic p21 and p27. J Cell Physiol 2014; 229: 1455-1465.